FT

Regeneron halts antibody trial in seriously ill Covid patients

Photo of Financial Times Financial Times
0 Less than a minute

Drug hailed as coronavirus ‘cure’ by Donald Trump will still be studied in mild-to-moderate cases

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

Global stocks slip as new Covid strain unsettles investors

Debate over vegan ‘sausages’ and ‘burgers’ heats up ahead of EU vote

German court convicts former member of Syrian intelligence

TikTok takes on Facebook with US ecommerce push

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button